BEMER AG operates in the medical engineering sector, conducts and supports research in the area of microcirculation, and develops physical treatment procedures to positively influence the aforementioned. The multi-patented and market-leading technology of the physical vascular therapy BEMER is available in different, innovative product lines, which the company distributes through its own, widely spread direct specialist distribution and the corresponding local representation in over 40 countries. The company’s registered office is in Triesen, Liechtenstein, where over 50 employees are employed.
BEMER was founded in 1998 by Peter Gleim as Innomed International AG, and in the year 2010 was renamed accordingly. Today, Gleim brings along many years of experience in managing the company as Chairman of the Board of Directors.
The need for health, a feeling of well-being and increased performance knows no bounds and is also not only common among older people. An ever-increasing target group is now confronted with exactly such problems that can be solved using BEMER technology. And this all over the world.
It is not only independent business prognoses that confirm the high turnover potential of BEMER products – a look at the present situation is sufficient to confirm the following: The people that BEMER has come to know and discovered up till now represent only the tip of the turnover iceberg. There is a great deal still to be done – and even more to be earned.
Why should you build on BEMER and not on a competitive product? Quite simple actually: There are no competitive products. Even university lecturer Prof. Dr. med. Rainer Klopp, one of the leading figures in the area of microcirculation research, confirms: “BEMER technology is the best researched and most effective physical treatment method in its area that is available to medicine today.”
If you are working with BEMER, you are working with an unparalleled top-quality product.
BEMER is successful because of its employees who take on the daily challenge of making BEMER even better. Management’s goal is to create the best possible conditions for this. This holds true both for research and for sales.
Robert Moll has been with the company since 1998 and became COO in 2003. He has been CEO since 2015 and is responsible for Factory Management, General Admin, Finance & Controlling, HR, Regulatory Affairs / QM, and UX / IT.